Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults.
Saved in:
| Title: | Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults. |
|---|---|
| Authors: | Nurkhametova D; Cochrane Russia Network of Volunteers, Kazan-Moscow, Russian Federation., Yudina EV; Cochrane Russia Network of Volunteers, Kazan-Moscow, Russian Federation.; City Children's Hospital №1, Kazan, Russian Federation., Wei Y; Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.; NIHR Applied Research Collaboration South West Peninsula, Exeter, UK., Abakumova T; Department of Biochemistry, Biotechnology and Pharmacology, Kazan (Volga Region) Federal University, Kazan, Russian Federation., Ziganshina LE; Cochrane Russia Network of Volunteers, Kazan-Moscow, Russian Federation.; Department of Pharmacology, Kazan State Medical University (KSMU), Kazan, Russian Federation.; Department of General and Clinical Pharmacology, Peoples' Friendship University of Russia, Named After Patrice Lumumba, Moscow, Russian Federation. |
| Source: | The International journal of risk & safety in medicine [Int J Risk Saf Med] 2026 Sep 17, pp. 9246479261461033. Date of Electronic Publication: 2026 Sep 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: IOS Press Country of Publication: United States NLM ID: 9100907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-6847 (Electronic) Linking ISSN: 09246479 NLM ISO Abbreviation: Int J Risk Saf Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
